Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network Peter K. Smith, MD, Robert E. Michler, MD, Y. Joseph Woo, MD, John H. Alexander, MD, MHS, John D. Puskas, MD, Michael K. Parides, PhD, Rebecca T. Hahn, MD, Judson B. Williams, MD, John M. Dent, MD, T. Bruce Ferguson, MD, Ellen Moquete, RN, BSN, Eric A. Rose, MD, Pierre Pagé, MD, Neal O. Jeffries, PhD, Patrick T. O’Gara, MD, Deborah D. Ascheim, MD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 1, Pages 111-117.e1 (January 2012) DOI: 10.1016/j.jtcvs.2011.05.006 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Study design flow chart. MR, Mitral regurgitation; CABG, coronary artery bypass grafting; LVESVI, left ventricular systolic volume index; LOS, length of stay; LVEF, left ventricular ejection fraction; AE’s, adverse events. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 111-117.e1DOI: (10.1016/j.jtcvs.2011.05.006) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions